Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Income Tax Income Tax + AT Income Tax - 2016 (1) TMI AT This

  • Login
  • Cases Cited
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2016 (1) TMI 413 - AT - Income Tax


Issues:
Appeal against deletion of addition of expenditure for replacement of re-membraning cells-II disregarding Supreme Court decision.

Analysis:
1. The appeal was against the deletion of an addition made by the Assessing Officer regarding the replacement cost of re-membraning in membrance cells-II. The Assessing Officer treated the expenditure as capital expenditure due to its nature and volume, adding the difference to the income of the assessee after allowing depreciation. The CIT(A) deleted this addition based on a Co-ordinate Bench decision in the appellant's own case for previous assessment years.

2. The Revenue contended that the deletion was erroneous, citing a Supreme Court decision in a similar case. However, the assessee argued that the issue had been decided in their favor by the Jurisdictional High Court in previous appeals. The Tribunal noted a mistake in the amount mentioned in the grounds of appeal by the Revenue, clarifying the correct figure for the addition.

3. The Tribunal referred to earlier decisions in the assessee's case, where the issue had been decided in their favor. The Tribunal also highlighted the decision of the Jurisdictional High Court, which extensively discussed the application of facts to the Supreme Court decision cited by the Revenue. The Tribunal emphasized the importance of consistency in tax matters and upheld the CIT(A)'s decision to delete the addition.

4. Ultimately, the Tribunal, following the decision of the Jurisdictional High Court in the assessee's case, found no fault in the CIT(A)'s order and deleted the addition. The Tribunal dismissed the Revenue's appeal, affirming the treatment of the cost of remembraning in membrance cell-II as revenue expenditure. The order was pronounced in open court on the specified date.

 

 

 

 

Quick Updates:Latest Updates